Cargando…

Differential MUC22 expression by epigenetic alterations in human lung squamous cell carcinoma and adenocarcinoma

Disruption in mucins (MUCs) is involved in cancer development and metastasis and is thus used as a biomarker. Non-small cell lung carcinoma (NSCLC) is characterized by heterogeneous genetic and epigenetic alterations. Lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) are the two primary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Shuye, Tian, Cuimeng, Li, Jianhui, Liu, Bin, Ma, Teng, Chen, Keqiang, Gong, Wanghua, Wang, Ji Ming, Huang, Jiaqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020203/ https://www.ncbi.nlm.nih.gov/pubmed/33786615 http://dx.doi.org/10.3892/or.2021.8029

Ejemplares similares

The G-Protein Coupled Formyl Peptide Receptors and Their Role in the Progression of Digestive Tract Cancer
por: Tian, Cuimeng, et al.
Publicado: (2020)

Requirement of CRAMP for mouse macrophages to eliminate phagocytosed E. coli through an autophagy pathway
por: Chen, Keqiang, et al.
Publicado: (2021)

Silencing of ATP4B of ATPase H(+)/K(+) Transporting Beta Subunit by Intragenic Epigenetic Alteration in Human Gastric Cancer Cells
por: Lin, Shuye, et al.
Publicado: (2017)

Expression of MUC1 and MUC4 in Gallbladder Adenocarcinoma
por: Kim, Su-Mi, et al.
Publicado: (2012)

Postoperative Radiotherapy for Patients with Completely Resected Pathological Stage IIIA-N2 Non-small Cell Lung Cancer: A Preferential Benefit for Squamous Cell Carcinoma
por: Tian, Cuimeng, et al.
Publicado: (2020)

Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours
por: Westgaard, Arne, et al.
Publicado: (2009)

Acquired resistance to EGFR-TKIs in NSCLC mediates epigenetic downregulation of MUC17 by facilitating NF-κB activity via UHRF1/DNMT1 complex
por: Lin, Shuye, et al.
Publicado: (2023)

CpG Site-Specific Methylation-Modulated Divergent Expression of PRSS3 Transcript Variants Facilitates Nongenetic Intratumor Heterogeneity in Human Hepatocellular Carcinoma
por: Lin, Shuye, et al.
Publicado: (2022)

NICD3 regulates the expression of MUC5AC and MUC2 by recruiting SMARCA4 and is involved in the differentiation of mucinous colorectal adenocarcinoma
por: Yan, Xiaodong, et al.
Publicado: (2022)

New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine
por: Xu, Hanli, et al.
Publicado: (2023)

MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung
por: Mawas, Amany Sayed, et al.
Publicado: (2018)

Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS)
por: Buyuk, Melek, et al.
Publicado: (2023)

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2015)

Differential Expression and Diagnostic Value of MUC5AC Glycoforms in Pancreatic Ductal Adenocarcinoma
por: Manne, Ashish, et al.
Publicado: (2023)

Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling)
por: Hanson, Ryan L., et al.
Publicado: (2016)

Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas
por: Yokoyama, Seiya, et al.
Publicado: (2016)

A novel anti-MUC1 antibody against the MUC1 cytoplasmic tail domain: use in sensitive identification of poorly differentiated cells in adenocarcinoma of the stomach
por: Yonezawa, Suguru, et al.
Publicado: (2012)

Beneficial effects of postoperative radiotherapy for IIIA‑N2 non‑small cell lung cancer after radical resection analysed using the propensity score‑matching method
por: Tian, Cuimeng, et al.
Publicado: (2023)

Inhibition of MUC1‐C regulates metabolism by AKT pathway in esophageal squamous cell carcinoma
por: GongSun, Xin, et al.
Publicado: (2018)

Alterations in Mucin Expression in Ovarian Mucinous Tumors: Immunohistochemical Analysis of MUC2, MUC5AC, MUC6, and CD10 Expression
por: Hirabayashi, Kenichi, et al.
Publicado: (2008)

Genomic alterations dissection revealed MUC4 mutation as a potential driver in lung adenocarcinoma local recurrence
por: Yuan, Chongze, et al.
Publicado: (2023)

The Contribution of Chemoattractant GPCRs, Formylpeptide Receptors, to Inflammation and Cancer
por: Liang, Weiwei, et al.
Publicado: (2020)

Altered Expression of Transmembrane Mucins, MUC1 and MUC4, in Bladder Cancer: Pathological Implications in Diagnosis
por: Kaur, Sukhwinder, et al.
Publicado: (2014)

Distinct contributions of cathelin‐related antimicrobial peptide (CRAMP) derived from epithelial cells and macrophages to colon mucosal homeostasis
por: Chen, Keqiang, et al.
Publicado: (2021)

Epigenetic Alterations from Barrett’s Esophagus to Esophageal Adenocarcinoma
por: Ergun, Pelin, et al.
Publicado: (2023)

Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2
por: Bizouarne, N, et al.
Publicado: (2001)

Targeting MUC1-C reverses the cisplatin resistance of esophageal squamous cell carcinoma in vitro and in vivo
por: Zhao, Yong-Qiang, et al.
Publicado: (2021)

MUC1 confers radioresistance in head and neck squamous cell carcinoma (HNSCC) cells
por: Huang, Tian-qiao, et al.
Publicado: (2020)

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma
por: Creaney, J, et al.
Publicado: (2008)

Altered Mucins (MUC) Trafficking in Benign and Malignant Conditions
por: Joshi, Suhasini, et al.
Publicado: (2014)

MUC1 as a target for CAR‐T therapy in head and neck squamous cell carinoma
por: Mei, Zi, et al.
Publicado: (2019)

Metformin sensitizes lung cancer cells to treatment by the tyrosine kinase inhibitor erlotinib
por: Wang, Xiaofei, et al.
Publicado: (2017)

MUC1 in lung adenocarcinoma: cross-sectional genetic and serological study
por: Horimasu, Yasushi, et al.
Publicado: (2017)

Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach
por: Zhu, Mengxuan, et al.
Publicado: (2022)

Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma
por: Xu, Rui, et al.
Publicado: (2019)

FAM3D is essential for colon homeostasis and host defense against inflammation associated carcinogenesis
por: Liang, Weiwei, et al.
Publicado: (2020)

MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
por: Betge, Johannes, et al.
Publicado: (2016)

MUC5AC and a Glycosylated Variant of MUC5B Alter Mucin Composition in Children With Acute Asthma
por: Welsh, Kathryn G., et al.
Publicado: (2017)

Differential Muc2 and Muc5ac secretion by stimulated guinea pig tracheal epithelial cells in vitro
por: Chorley, Brian N, et al.
Publicado: (2006)

MUC4 and MUC1 Expression in Adenocarcinoma of the Stomach Correlates with Vessel Invasion and Lymph Node Metastasis: An Immunohistochemical Study of Early Gastric Cancer
por: Tamura, Yukihiro, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6ilisnf5nu2ho8krgfevn5v464